ABT vs. DOV
ABT (Abbott Laboratories) and DOV (Dover Corporation) are both stocks. ABT operates in Medical Devices (Healthcare), while DOV operates in Specialty Industrial Machinery (Industrials). Over the past 10 years, ABT returned 11.01%/yr vs 16.12%/yr for DOV. At a 0.28 correlation, their price movements are largely independent.
Performance
ABT vs. DOV - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, ABT achieves a -26.95% return, which is significantly lower than DOV's 11.26% return. Over the past 10 years, ABT has underperformed DOV with an annualized return of 11.01%, while DOV has yielded a comparatively higher 16.12% annualized return.
ABT
- 1D
- -0.63%
- 1M
- 7.33%
- YTD
- -26.95%
- 6M
- -25.03%
- 1Y
- -30.87%
- 3Y*
- -1.86%
- 5Y*
- -1.83%
- 10Y*
- 11.01%
DOV
- 1D
- 0.67%
- 1M
- -1.41%
- YTD
- 11.26%
- 6M
- 13.56%
- 1Y
- 21.73%
- 3Y*
- 16.60%
- 5Y*
- 8.83%
- 10Y*
- 16.12%
ABT vs. DOV - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | -26.95% | 12.87% | 4.81% | 2.26% | -20.68% | 30.53% | 28.04% | 22.08% | 29.06% | 52.03% |
DOV Dover Corporation | 11.26% | 5.24% | 23.35% | 15.22% | -24.34% | 45.73% | 11.53% | 65.80% | -11.11% | 37.68% |
Correlation
The correlation between ABT and DOV is 0.10, meaning there is essentially no relationship between their price movements. Each responds to its own set of market drivers, making them strong candidates for combining in a diversified portfolio.
| Correlation | |
|---|---|
Correlation (1Y) Calculated over the trailing 1-year period | 0.10 |
Correlation (3Y) Calculated over the trailing 3-year period | 0.20 |
Correlation (5Y) Calculated over the trailing 5-year period | 0.34 |
Correlation (10Y) Calculated over the trailing 10-year period | 0.35 |
Correlation (All Time) Calculated using the full available price history since Jul 2, 1985 | 0.28 |
The correlation between ABT and DOV shifts across timeframes, from 0.10 (1 year) to 0.35 (10 years), reflecting how their relationship changes across market environments.
Fundamentals
ABT:
$158.10B
DOV:
$29.38B
ABT:
$3.59
DOV:
$8.01
ABT:
25.21
DOV:
26.98
ABT:
1.57
DOV:
1.12
ABT:
3.51
DOV:
3.59
ABT:
2.39
DOV:
3.92
ABT:
$45.13B
DOV:
$8.28B
ABT:
$25.45B
DOV:
$3.27B
ABT:
$10.80B
DOV:
$1.78B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
ABT vs. DOV — Risk / Return Rank
ABT
DOV
ABT vs. DOV - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Abbott Laboratories (ABT) and Dover Corporation (DOV). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
| ABT | DOV | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -2.18 | ||
| Sortino ratioReturn per unit of downside risk | -3.25 | ||
| Omega ratioGain probability vs. loss probability | 0.77 | 1.18 | -0.40 |
| Calmar ratioReturn relative to maximum drawdown | -0.79 | 1.42 | -2.22 |
| Martin ratioReturn relative to average drawdown | -1.79 | 3.27 | -5.06 |
Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month. | |||
Loading charts...
Sharpe Ratios by Period
| ABT | DOV | Difference | |
|---|---|---|---|
Sharpe Ratio (1Y)Calculated over the trailing 1-year period | -1.27 | 0.91 | -2.18 |
Sharpe Ratio (5Y)Calculated over the trailing 5-year period | -0.08 | 0.36 | -0.44 |
Sharpe Ratio (10Y)Calculated over the trailing 10-year period | 0.47 | 0.61 | -0.14 |
Sharpe Ratio (All Time)Calculated using the full available price history | 0.49 | 0.46 | +0.03 |
Drawdowns
ABT vs. DOV - Drawdown Comparison
The maximum ABT drawdown since its inception was -45.66%, smaller than the maximum DOV drawdown of -58.22%. Use the drawdown chart below to compare losses from any high point for ABT and DOV.
Loading charts...
Drawdown Indicators
| ABT | DOV | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -45.66% | -58.22% | +12.56% |
Max Drawdown (1Y)Largest decline over 1 year | -38.99% | -15.34% | -23.65% |
Max Drawdown (3Y)Largest decline over 3 years | -39.64% | -26.59% | -13.05% |
Max Drawdown (5Y)Largest decline over 5 years | -39.64% | -35.56% | -4.08% |
Max Drawdown (10Y)Largest decline over 10 years | -39.64% | -45.24% | +5.60% |
Current DrawdownCurrent decline from peak | -33.84% | -6.90% | -26.94% |
Average DrawdownAverage peak-to-trough decline | -10.83% | -13.14% | +2.31% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 17.23% | 6.67% | +10.56% |
Volatility
ABT vs. DOV - Volatility Comparison
Abbott Laboratories (ABT) has a higher volatility of 8.41% compared to Dover Corporation (DOV) at 5.74%. This indicates that ABT's price experiences larger fluctuations and is considered to be riskier than DOV based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| ABT | DOV | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 8.41% | 5.74% | +2.67% |
Volatility (6M)Calculated over the trailing 6-month period | 19.45% | 17.99% | +1.46% |
Volatility (1Y)Calculated over the trailing 1-year period | 24.42% | 24.02% | +0.40% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 22.04% | 24.80% | -2.76% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 23.67% | 26.74% | -3.07% |
Dividends
ABT vs. DOV - Dividend Comparison
ABT's dividend yield for the trailing twelve months is around 2.70%, more than DOV's 0.96% yield.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
ABT Abbott Laboratories | 2.70% | 1.88% | 1.95% | 1.85% | 1.71% | 1.28% | 1.32% | 1.47% | 1.55% | 1.86% | 2.71% | 2.14% |
DOV Dover Corporation | 0.96% | 1.06% | 1.09% | 1.32% | 1.48% | 1.10% | 1.56% | 1.68% | 2.55% | 1.80% | 2.30% | 2.67% |
Financials
ABT vs. DOV - Financials Comparison
This section allows you to compare key financial metrics between Abbott Laboratories and Dover Corporation. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
ABT vs. DOV - Profitability Comparison
ABT - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported a gross profit of 6.28B and revenue of 11.16B. Therefore, the gross margin over that period was 56.3%.
DOV - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Jun 2026, Dover Corporation reported a gross profit of 798.14M and revenue of 2.05B. Therefore, the gross margin over that period was 38.9%.
ABT - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported an operating income of 1.84B and revenue of 11.16B, resulting in an operating margin of 16.5%.
DOV - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Jun 2026, Dover Corporation reported an operating income of 305.91M and revenue of 2.05B, resulting in an operating margin of 14.9%.
ABT - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Abbott Laboratories reported a net income of 1.08B and revenue of 11.16B, resulting in a net margin of 9.7%.
DOV - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Jun 2026, Dover Corporation reported a net income of 238.43M and revenue of 2.05B, resulting in a net margin of 11.6%.
Frequently Asked Questions
ABT and DOV have a correlation of 0.10, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
ABT has higher volatility (8.41%) compared to DOV (5.74%). In terms of maximum drawdown, ABT dropped -45.66% vs DOV's -58.22%.
DOV currently has the higher Sharpe Ratio (0.91 vs -1.27), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for ABT and DOV
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer